Literature DB >> 20386774

The prevalence and clinical impact of obesity in adults with Marfan syndrome.

Anji T Yetman1, Brian W McCrindle.   

Abstract

BACKGROUND: Patients with Marfan syndrome characteristically have an asthenic body habitus and are considered to be exempt from the obesity epidemic.
OBJECTIVE: To examine the prevalence and clinical impact of obesity in a cohort of adults with Marfan syndrome.
METHODS: Fifty outpatients (30 female) with a mean (+/- SD) age of 38+/-13 years were studied. Demographic variables including previously identified risk factors for aortic dissection were recorded. Body mass index (BMI) was determined and patients were classified as normal (BMI less than 25 kgm2), overweight (BMI 25 kgm2 to 29.9 kgm2) or obese (BMI 30 kgm2 or greater). Other cardiovascular risk factors were examined. An adverse clinical outcome was defined as either the attainment of surgical criteria for aortic root replacement or the presence of aortic dissection.
RESULTS: A family history of aortic dissection was present in 13 (26%) patients. In 23 (46%) patients, there was no known family history of Marfan syndrome. Mean BMI was 25.4+/-7.4 kgm2, with 18 (36%) patients having an elevated BMI. Positive smoking status was present in 15 (30%), hypertension in 13 (26%) and hyperlipidemia in 19 (38%) patients. Adverse clinical outcome was present in 27 (54%) patients. Logistic regression analysis revealed only index case (OR 44; P<0.001) and higher BMI (OR 1.2; P=0.04) to be significantly and independently associated with increased risk of adverse clinical outcome.
CONCLUSIONS: Obesity is common in adults with Marfan syndrome and is associated with an increased risk of aortic complications.

Entities:  

Mesh:

Year:  2010        PMID: 20386774      PMCID: PMC2886547          DOI: 10.1016/s0828-282x(10)70370-6

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  19 in total

Review 1.  The clinical implications of endothelial dysfunction.

Authors:  Michael E Widlansky; Noyan Gokce; John F Keaney; Joseph A Vita
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Natural history of cardiovascular manifestations in Marfan syndrome.

Authors:  C D van Karnebeek; M S Naeff; B J Mulder; R C Hennekam; M Offringa
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

3.  Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival.

Authors:  D I Silverman; J Gray; M J Roman; A Bridges; K Burton; M Boxer; R B Devereux; P Tsipouras
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094

4.  Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation.

Authors:  Matthew J Eagleton; Nicole Ballard; Erin Lynch; Sunita D Srivastava; Gilbert R Upchurch; James C Stanley
Journal:  J Surg Res       Date:  2006-05-22       Impact factor: 2.192

Review 5.  Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease.

Authors:  R M Touyz
Journal:  Braz J Med Biol Res       Date:  2004-07-20       Impact factor: 2.590

Review 6.  TGF-beta1 and angiotensin networking in cardiac remodeling.

Authors:  Stephan Rosenkranz
Journal:  Cardiovasc Res       Date:  2004-08-15       Impact factor: 10.787

7.  Relative sitting height and the interpretation of the body mass index.

Authors:  N G Norgan
Journal:  Ann Hum Biol       Date:  1994 Jan-Feb       Impact factor: 1.533

8.  Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome.

Authors:  R W Jeremy; H Huang; J Hwa; H McCarron; C F Hughes; J G Richards
Journal:  Am J Cardiol       Date:  1994-08-15       Impact factor: 2.778

9.  Obesity accelerates the progression of coronary atherosclerosis in young men.

Authors:  Henry C McGill; C Alex McMahan; Edward E Herderick; Arthur W Zieske; Gray T Malcom; Richard E Tracy; Jack P Strong
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

10.  Life expectancy in the Marfan syndrome.

Authors:  D I Silverman; K J Burton; J Gray; M S Bosner; N T Kouchoukos; M J Roman; M Boxer; R B Devereux; P Tsipouras
Journal:  Am J Cardiol       Date:  1995-01-15       Impact factor: 2.778

View more
  5 in total

1.  Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndrome.

Authors:  Munenori Takata; Eisuke Amiya; Masafumi Watanabe; Kazuko Omori; Yasushi Imai; Daishi Fujita; Hiroshi Nishimura; Masayoshi Kato; Tetsuro Morota; Kan Nawata; Atsuko Ozeki; Aya Watanabe; Shuichi Kawarasaki; Yumiko Hosoya; Tomoko Nakao; Koji Maemura; Ryozo Nagai; Yasunobu Hirata; Issei Komuro
Journal:  Heart Vessels       Date:  2013-07-14       Impact factor: 2.037

2.  Sleep apnea and the impact on cardiovascular risk in patients with Marfan syndrome.

Authors:  Laura Muiño-Mosquera; Fré Bauters; Karlien Dhondt; Hans De Wilde; Luc Jordaens; Katya De Groote; Daniel De Wolf; Katrien Hertegonne; Julie De Backer
Journal:  Mol Genet Genomic Med       Date:  2019-06-27       Impact factor: 2.183

Review 3.  Medical treatment of aortic aneurysms in Marfan syndrome and other heritable conditions.

Authors:  Christine H Attenhofer Jost; Matthias Greutmann; Heidi M Connolly; Roland Weber; Marianne Rohrbach; Angela Oxenius; Oliver Kretschmar; Thomas F Luscher; Gabor Matyas
Journal:  Curr Cardiol Rev       Date:  2014-05

4.  Higher admission rates and in-hospital mortality for acute type A aortic dissection during Influenza season: a single center experience.

Authors:  Carmel Ashur; Elizabeth Norton; Linda Farhat; Anna Conlon; Cristen Willer; James B Froehlich; David J Pinsky; Karen M Kim; Shinichi Fukuhara; Michael G Deeb; Himanshu Patel; Kim A Eagle; Bo Yang; Marion A Hofmann Bowman
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

5.  Body Image in Patients with Marfan Syndrome.

Authors:  Laura Birke Hansen; Yskert von Kodolitsch; Friedrich Schroeder; Dieter Benninghoven
Journal:  J Clin Med       Date:  2020-04-03       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.